HawkCell

Strategic area of application
Human Medicine

Application market
Cardiology - Neurological diseases - Oncology

Activities
Diagnostics

Technologies
(Bio) Informatics & software - Imaging

Presentation of company's activity
HawkCell provides in vivo 3D MRI services on animals (from 1 to 150kg). We extend the potential of preclinical studies with accurate and quantitative analysis of physiopathology processes for testing new drugs or medical devices. Using MRI, HawkCell offers additional in vivo information about tissue structure, biochemical content and functional parameters for neurology, cardiology, oncology… applications in controlled health status. Thus, we provide in vivo insights about drugs and medical devices, such as innocuity, biocompatibility… Our 1.5T MRI system and post-processing algorithms have been optimized for animal imaging to reduce study time, and to increase financial profits and the amount of in vivo data.

Key features of company
- Imaging facility with a 1.5T MRI system for animals (rat to pig) - Strategic partners - Reactivity - Focused on ethics

Recent news
2018/09 - HawkCell integrates the 1KTech program of 1Kubator
2018/12 - HawkCell received a 11k€ grant from Inovizi
2019/02 - HawkCell gets a 100k€ R&D project from Pulsalys for the design of a new generation of MRI coils
2019/03 - HawkCell wins "Les Lions de Demain" Challenge recognizing an innovative solution
2019/03 - HawkCell becomes part of LyonBioPôle cluster
2019/04 - HawkCell becomes part of Minalogic cluster

Skills and know-how
- Expertise in high field MRI from protocol design to acquisition and image post-processing. - Innovative customized MRI coils for each animal morphology or organs to image. - Optimized and dedicated MRI protocols for each study

Higlights
Acquisition and post-processing of NMR images for neurology, cardiology and oncology applications but also for gastrointestinal and osteoarticular diseases.